Press Releases
Angiotech Pharmaceuticals to participate in US Bancorp Piper Jaffray Health Care Conference
January 20, 2004
VANCOUVER, Jan 20, 2004 /PRNewswire-FirstCall via COMTEX/ --Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), is scheduled to participate in the US Bancorp Piper Jaffray Health Care Conference hosted by US Bancorp Piper Jaffray.
William Hunter, President and CEO of Angiotech, will be making a 25- minute presentation at the conference on Tuesday, January 27th beginning at 3:30 pm EST (12:30 pm PST).
A live audio only webcast of Dr. Hunter's remarks will be available to all interested parties at Angiotech's website at www.angiotech.com in the Investor Relations section or through US Bancorp Piper Jaffray's conference website at http://www.gotoanalysts.com/hccwebcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.
This webcast is being hosted by US Bancorp Piper Jaffray. The replay will be archived and available in the Investor Relations section of Angiotech's website at www.angiotech.com.
Angiotech Pharmaceuticals, Inc. is dedicated to enhancing the performance of medical devices and biomaterials through the innovative use of pharmacotherapeutics. To find out more about Angiotech Pharmaceuticals, Inc (NASDAQ: ANPI, TSX: ANP), visit our website at www.angiotech.com.
Company Contacts: Rui Avelar (analysts), ext 6996 Ian Harper (investors and media), ext 6933 Phone: (604) 221-7676 Web: www.angiotech.com Email: info@angio.com
SOURCE Angiotech Pharmaceuticals, Inc.
Company Contacts: Rui Avelar (analysts), ext 6996; Ian Harper (investors and media), ext 6933, Phone: 604-221-7676; Web: www.angiotech.com, Email: info@angio.com (ANP. ANPI)
Copyright (C) 2004 PR Newswire. All rights reserved.